 Candriam Luxembourg S.C.A. lessened its holdings in Esperion Therapeutics Inc NASDAQ:ESPR by 45.7 in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 116,804 shares of the biopharmaceutical companys stock after selling 98,292 shares during the period. Candriam Luxembourg S.C.A. owned 0.42 ... 